Development strategy and lessons learned for a 10-valent pneumococcal conjugate vaccine (PNEUMOSIL®)

Pneumococcal conjugate vaccines (PCVs) have proven to be the best way to prevent severe childhood pneumococcal disease but until recently have been difficult for many countries to afford sustainably. In 2008, the Serum Institute of India, Pvt. Ltd. and PATH entered into a collaboration, funded in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Alderson, Mark R., Sethna, Vistasp, Newhouse, Lauren C., Lamola, Steve, Dhere, Rajeev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475595/
https://www.ncbi.nlm.nih.gov/pubmed/33625961
http://dx.doi.org/10.1080/21645515.2021.1874219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475595/
https://www.ncbi.nlm.nih.gov/pubmed/33625961
http://dx.doi.org/10.1080/21645515.2021.1874219

Ejemplares similares